These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 17671191)

  • 1. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
    Zhang X; Wang JF; Kunos G; Groopman JE
    Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
    Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
    Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
    Nishimura K; Ueda K; Sakakibara S; Ishikawa K; Chen J; Okuno T; Yamanishi K
    J Hum Virol; 2001; 4(6):296-305. PubMed ID: 12082396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
    Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
    Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.
    Foreman KE; Friborg J; Kong WP; Woffendin C; Polverini PJ; Nickoloff BJ; Nabel GJ
    N Engl J Med; 1997 Jan; 336(3):163-71. PubMed ID: 8988896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
    Brown HJ; McBride WH; Zack JA; Sun R
    Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation.
    Arvanitakis L; Geras-Raaka E; Varma A; Gershengorn MC; Cesarman E
    Nature; 1997 Jan; 385(6614):347-50. PubMed ID: 9002520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.
    Cerimele F; Curreli F; Ely S; Friedman-Kien AE; Cesarman E; Flore O
    J Virol; 2001 Mar; 75(5):2435-43. PubMed ID: 11160746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
    Harrison SM; Whitehouse A
    FEBS Lett; 2008 Sep; 582(20):3080-4. PubMed ID: 18692049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus in Kaposi's sarcoma occurring in immunosuppressed renal transplant recipients.
    Kedda MA; Margolius L; Kew MC; Swanepoel C; Pearson D
    Clin Transplant; 1996 Oct; 10(5):429-31. PubMed ID: 8930456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
    Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
    Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
    Cho HJ; Yu F; Sun R; Lee D; Song MJ
    Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.